These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3093680)

  • 1. Synthesis and aldose reductase inhibitory activity of substituted 2-oxoquinoline-1-acetic acid derivatives.
    DeRuiter J; Brubaker AN; Whitmer WL; Stein JL
    J Med Chem; 1986 Oct; 29(10):2024-8. PubMed ID: 3093680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro aldose reductase inhibitory activity of compounds containing an N-acylglycine moiety.
    DeRuiter J; Swearingen BE; Wandrekar V; Mayfield CA
    J Med Chem; 1989 May; 32(5):1033-8. PubMed ID: 2496229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro aldose reductase inhibitory activity of substituted N-benzenesulfonylglycine derivatives.
    DeRuiter J; Brubaker AN; Garner MA; Barksdale JM; Mayfield CA
    J Pharm Sci; 1987 Feb; 76(2):149-52. PubMed ID: 3106615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and rat lens aldose reductase inhibitory activity of some benzopyran-2-ones.
    Brubaker AN; DeRuiter J; Whitmer WL
    J Med Chem; 1986 Jun; 29(6):1094-9. PubMed ID: 3086557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid derivatives of benzisothiazole-1,1-dioxide as inhibitors of rat lens aldose reductase.
    Da Settimo A; Primofiore G; La Motta C; Da Settimo F; Simorini F; Boldrini E; Bianchini P
    Farmaco; 1996 Apr; 51(4):261-7. PubMed ID: 8645413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of 2-(arylamino)-4(3H)-quinazolinones as novel inhibitors of rat lens aldose reductase.
    DeRuiter J; Brubaker AN; Millen J; Riley TN
    J Med Chem; 1986 May; 29(5):627-9. PubMed ID: 3084783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and aldose reductase-inhibitory activity of imidazopyrroloquinoline esters.
    Urakami T; Tanaka A; Tanimoto T; Niki E
    Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1493-7. PubMed ID: 8795268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N- and 2-substituted N-(phenylsulfonyl)glycines as inhibitors of rat lens aldose reductase.
    DeRuiter J; Borne RF; Mayfield CA
    J Med Chem; 1989 Jan; 32(1):145-51. PubMed ID: 2491890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel inhibitors of rat lens aldose reductase: N-[[(substituted amino)phenyl]sulfonyl]glycines.
    Mayfield CA; DeRuiter J
    J Med Chem; 1987 Sep; 30(9):1595-8. PubMed ID: 3114491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and aldose reductase-inhibitory activity of benzo[b]furan derivatives possessing a carboxymethylsulfamoyl group.
    Ohishi Y; Mukai T; Nagahara M; Yajima M; Kajikawa N
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2398-405. PubMed ID: 2514045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzisothiazole-1,1-dioxide alkanoic acid derivatives as inhibitors of rat lens aldose reductase.
    Primofiore G; Da Settimo F; La Motta C; Simorini F; Minutolo A; Boldrini E
    Farmaco; 1997 Oct; 52(10):583-8. PubMed ID: 9507669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors.
    Pau A; Asproni B; Murineddu G; Boatto G; Grella GE; Rakowitz D; Costantino L; Pinna GA
    Med Chem; 2006 Jan; 2(1):39-45. PubMed ID: 16787354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of irreversible inhibitors of aldose reductase.
    Ares JJ; Kador PF; Miller DD
    J Med Chem; 1986 Nov; 29(11):2384-9. PubMed ID: 3097318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity correlation of flavonoids for inhibition of bovine lens aldose reductase.
    Iinuma M; Tanaka T; Mizuno M; Katsuzaki T; Ogawa H
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1813-5. PubMed ID: 2509087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel series of pyrrole based chemotypes and their evaluation as selective aldose reductase inhibitors. A case of bioisosterism between a carboxylic acid moiety and that of a tetrazole.
    Pegklidou K; Koukoulitsa C; Nicolaou I; Demopoulos VJ
    Bioorg Med Chem; 2010 Mar; 18(6):2107-2114. PubMed ID: 20189816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity studies of aldose reductase inhibitors containing the 4-oxo-4h-chromen ring system.
    Kador PF; Sharpless NE
    Biophys Chem; 1978 Mar; 8(1):81-5. PubMed ID: 417745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids.
    Cerelli MJ; Curtis DL; Dunn JP; Nelson PH; Peak TM; Waterbury LD
    J Med Chem; 1986 Nov; 29(11):2347-51. PubMed ID: 3097317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and aldose reductase inhibitory activity of 7-sulfamoylxanthone-2-carboxylic acids.
    Pfister JR; Wymann WE; Mahoney JM; Waterbury LD
    J Med Chem; 1980 Nov; 23(11):1264-7. PubMed ID: 6779009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones.
    Bruno G; Costantino L; Curinga C; Maccari R; Monforte F; Nicoló F; Ottanà R; Vigorita MG
    Bioorg Med Chem; 2002 Apr; 10(4):1077-84. PubMed ID: 11836118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.